These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38749721)

  • 1. Patient perspectives on treatment for mantle cell lymphoma and chronic lymphocytic leukemia in Japan.
    Kiguchi T; Hiramatsu Y; Ota S; Uchiyama M; Matsuo M; Okamura M; Morimoto S; Tanizawa Y; Tajimi M; Payakachat N
    J Clin Exp Hematop; 2024 Jun; 64(2):119-128. PubMed ID: 38749721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.
    Markowitz JT; Mazerolle F; Lovell T; Hess LM; Abada PB; Regnault A; Payakachat N
    J Patient Rep Outcomes; 2024 Jan; 8(1):8. PubMed ID: 38252198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.
    Hoeller S; Zhou Y; Kanagal-Shamanna R; Xu-Monette ZY; Hoehn D; Bihl M; Swerdlow SH; Rosenwald A; Ott G; Said J; Dunphy CH; Bueso-Ramos CE; Lin P; Wang M; Miranda RN; Tzankov A; Medeiros LJ; Young KH
    Hum Pathol; 2013 Jan; 44(1):110-21. PubMed ID: 22944294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
    Asaad NY; Abd El-Wahed MM; Dawoud MM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and antitumor activity of acalabrutinib for relapsed/refractory B-cell malignancies: A Japanese phase I study.
    Izutsu K; Ando K; Ennishi D; Shibayama H; Suzumiya J; Yamamoto K; Ichikawa S; Kato K; Kumagai K; Patel P; Iizumi S; Hayashi N; Kawasumi H; Murayama K; Nagai H
    Cancer Sci; 2021 Jun; 112(6):2405-2415. PubMed ID: 33728735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
    Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
    Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States.
    Peloquin S; Cymbalista F; Dreyling M; Shah NN; Murray S; Del Fiacco R; Muehlenbein CE; Lazure P
    BMC Cancer; 2024 Aug; 24(1):1003. PubMed ID: 39138575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
    Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
    Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
    Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
    Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
    J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.
    Ibrahim F; Al Sabbagh A; Amer A; Soliman DS; Al Sabah H
    Am J Case Rep; 2020 Mar; 21():e921131. PubMed ID: 32150530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Sun Y; Wang SA; Sun T
    Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
    Yoshino T; Tanaka T; Sato Y
    J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma.
    O'Brien S; Hillmen P; Coutre S; Barr PM; Fraser G; Tedeschi A; Burger JA; Dilhuydy MS; Hess G; Moreno C; Cramer P; Liu E; Chang S; Vermeulen J; Styles L; Howes A; James DF; Patel K; Graef T; Valentino R
    Clin Lymphoma Myeloma Leuk; 2018 Oct; 18(10):648-657.e15. PubMed ID: 30061088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program.
    Mulligan SP; Opat S; Cheah CY; Kuss B; Hertzberg M; Marlton P; Poplar S; Puig A; McGeachie M; Weinkove R; Tam CS
    Leuk Lymphoma; 2023 Feb; 64(2):312-318. PubMed ID: 36423351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma, malt lymphoma, small lymphocytic lymphoma, and follicular lymphoma of the oral cavity: An update.
    Wagner VP; Rodrigues-Fernandes CI; Carvalho MVR; Dos Santos JN; Barra MB; Hunter KD; Aguirre-Urizar JM; van Heerden WFP; Vargas PA; Fonseca FP; Martins MD
    J Oral Pathol Med; 2021 Jul; 50(6):622-630. PubMed ID: 34101256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
    Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
    Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
    Zhao Y; McCracken J; Rehder C; Wang E
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e310-e313. PubMed ID: 34840090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
    Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
    Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.